Alzamend Neuro, Inc.

8-K Entered a material agreement; Delisting notice or listing-rule failure; Unregistered sale of equity; Amended charter or bylaws Aug 3, 2026 10-K Fiscal year ended 2026-04-30 Jul 22, 2026 8-K Other events Jul 21, 2026 8-K Shareholder vote results Apr 17, 2026 8-K Delisting notice or listing-rule failure Mar 20, 2026 10-Q Quarter ended 2026-01-31 Mar 11, 2026 8-K Entered a material agreement Mar 6, 2026 10-Q Quarter ended 2025-10-31 Dec 9, 2025 8-K Other events Nov 18, 2025 8-K Amended charter or bylaws Oct 14, 2025 8-K Unregistered sale of equity Oct 9, 2025 8-K Unregistered sale of equity Sep 25, 2025 10-Q Quarter ended 2025-07-31 Sep 10, 2025 8-K Unregistered sale of equity Aug 1, 2025 8-K Results of operations (earnings release) Jul 23, 2025 10-K Fiscal year ended 2025-04-30 Jul 22, 2025 8-K Amended charter or bylaws Jul 9, 2025 8-K Amended charter or bylaws; Regulation FD disclosure May 8, 2025 8-K Shareholder vote results Apr 25, 2025 10-Q Quarter ended 2025-01-31 Mar 10, 2025 8-K Amended charter or bylaws Mar 3, 2025 8-K Entered a material agreement; Unregistered sale of equity Feb 28, 2025 8-K Results of operations (earnings release) Dec 12, 2024 10-Q Quarter ended 2024-10-31 Dec 11, 2024 8-K Regulation FD disclosure Oct 15, 2024 8-K Entered a material agreement Oct 3, 2024 10-Q Quarter ended 2024-07-31 Sep 11, 2024 8-K Regulation FD disclosure Jul 31, 2024 10-K Fiscal year ended 2024-04-30 Jul 30, 2024 8-K Amended charter or bylaws; Regulation FD disclosure Jul 12, 2024 8-K Shareholder vote results Jul 8, 2024 8-K Regulation FD disclosure May 22, 2024 8-K Regulation FD disclosure May 15, 2024 8-K May 13, 2024 8-K/A Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Regulation FD disclosure May 10, 2024 8-K Entered a material agreement; Regulation FD disclosure May 9, 2024 8-K Changed accountants May 9, 2024 8-K Terminated a material agreement; Regulation FD disclosure May 7, 2024 8-K Shareholder vote results May 1, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 30, 2024